HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia.

Abstract
CD38 expression and chromosomal abnormalities are novel prognostic factors in chronic lymphocytic leukaemia (CLL). However, their value remains undetermined. CD38 was evaluated in 123 patients and chromosomal aberrations in 111 cases with fluorescence in situ hybridization (FISH). CD38 expression was found in 27% of the cases. In addition, seven out of 32 CD38- patients became CD38+ during evolution of the disease. Chromosomal abnormalities included isolated 13q deletion (40%), 12q trisomy (14%), 11q deletion (without 17p deletion) (14%) and 17p deletion (7%). CD38 expression was significantly associated with Binet stages B and C, atypical morphology and 11q deletion. On univariate analysis of survival estimates, advanced Binet stages, CD38+ phenotype, atypical morphology and 11q or 17p deletions were associated with shorter event-free survival (EFS), treatment-free interval (TFI) and overall survival (OS). Multivariate analysis identified both Binet stages and CD38 as independent prognostic factors with regard to EFS and TFI. However, CD38 appeared as an independent factor for OS when restricted to Binet stage A. Chromosomal aberrations were re-evaluated during evolution in 31 cases. The 17p deletion was the most frequent new chromosomal abnormality (35%) and significantly associated with death (64%). In conclusion, CD38 expression and secondary 17p deletion are important poor prognostic indicators, especially in Binet stage A CLL.
AuthorsPatrice Chevallier, Dominique Penther, Hervé Avet-Loiseau, Nelly Robillard, Norbert Ifrah, Béatrice Mahé, Mohamed Hamidou, Hervé Maisonneuve, Philippe Moreau, Henri Jardel, Jean Luc Harousseau, Régis Bataille, Richard Garand
JournalBritish journal of haematology (Br J Haematol) Vol. 116 Issue 1 Pg. 142-50 (Jan 2002) ISSN: 0007-1048 [Print] England
PMID11841407 (Publication Type: Journal Article)
Chemical References
  • Antigens, CD
  • Antigens, Differentiation
  • Membrane Glycoproteins
  • ADP-ribosyl Cyclase
  • CD38 protein, human
  • NAD+ Nucleosidase
  • ADP-ribosyl Cyclase 1
Topics
  • ADP-ribosyl Cyclase
  • ADP-ribosyl Cyclase 1
  • Aged
  • Antigens, CD
  • Antigens, Differentiation (immunology)
  • Chromosome Aberrations
  • Disease-Free Survival
  • Female
  • Gene Deletion
  • Humans
  • In Situ Hybridization, Fluorescence
  • Leukemia, Lymphocytic, Chronic, B-Cell (genetics, immunology, mortality)
  • Male
  • Membrane Glycoproteins
  • Middle Aged
  • NAD+ Nucleosidase (immunology)
  • Prognosis
  • Retrospective Studies
  • Survival Rate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: